Mary E. Smith

发表

The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis

J. Frank, H. McFarland, L. Stone, 1995, Annals of neurology.

Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

Roland Martin, J. Frank, Roland Martin, 1992, Annals of neurology.

Serial contrast‐enhanced magnetic resonance imaging in patients with early relapsing–remitting multiple sclerosis: Implications for treatment trials

J A Frank, P S Albert, H. McFarland, 1994, Annals of neurology.

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection

D. Katzenstein, C. Yiannoutsos, D. Clifford, 2000, Neurology.

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.

S. Lee, W. Borkowsky, L. Mofenson, 2000, JAMA.

Systemic histiocytosis presenting as multiple sclerosis

C. Kufta, Jonathan O. Harris, Joseph Frank, 1993, Annals of neurology.

Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy

D. Katzenstein, C. Yiannoutsos, D. Clifford, 2001, Neurology.

Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

H. McFarland, C. Raine, M. Racke, 1999, The American journal of pathology.

Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis

P. S. Albert, C. DeCarli, P. Albert, 1995, Neurology.

Short echo time proton MR spectroscopic imaging.

C T Moonen, P. V. van Zijl, S. Posse, 1993, Journal of computer assisted tomography.